European Psychiatry (Jun 2022)

Electroconvulsive therapy in children and adolescents

  • M. Esperesate Pajares,
  • C. Pastor Jordá,
  • M. Taracena Cuerda,
  • R. Puente García,
  • A.M. Jiménez Bidón

DOI
https://doi.org/10.1192/j.eurpsy.2022.1130
Journal volume & issue
Vol. 65
pp. S445 – S445

Abstract

Read online

Introduction Despite its good results and tolerability in adults, electroconvulsive therapy (ECT) is barely administered in children and adolescents, with scarce evidence in these patients. Objectives We aim to summarize the data available to give a clearer view of how children and adolescents might benefit from ECT. Methods We’ve done a bibliographic review in PubMed and Cochrane Library searching for articles that include the terms “electroconvulsive therapy” and “adolescents” and/or “children” and their variations. Results Current evidence supports the use of ECT in various indications as mood disorders, schizophrenia spectrum disorders, catatonia, neuroleptic malignant syndrome and self-injurious behaviours associated with autism, Tourette’s syndrome or intellectual disability. The efficacy and safety it’s comparable to adults and there are no absolute contraindications. Side-effect profile it’s also similar to the general population, reporting as the most frequent adverse effects headache, generalized body aching, and nausea or vomiting. Conclusions ECT is an effective and safe treatment for severe mental disorders in children and adolescents. Disclosure No significant relationships.

Keywords